RDF/XML JSON-LD N3/Turtle RDF/JSON

Díaz Villamarín, Xando Author

Open Access

A New Pharmacogenetic Algorithm to Predict the Most Appropriate Dosage of Acenocoumarol for Stable Anticoagulation in a Mixed Spanish Population.

  • Tong H.Y.
  • Dávila-Fajardo C.L.
  • Borobia A.M.
  • Martínez-González L.J.
  • Lubomirov R.
  • León L.M.P.
  • Bañares M.J.B.
  • Díaz-Villamarín X.
  • Fernández-Capitán C.
  • Barrera J.C.
  • Carcas A.J.
... View more Collapse

PloS one - 15/03/2016

10.1371/journal.pone.0150456

Cite count: 19 (Scopus)

Genetic polymorphisms influence on the response to clopidogrel in peripheral artery disease patients following percutaneous transluminal angioplasty.

  • Díaz-Villamarín X.
  • Dávila-Fajardo C.L.
  • Martínez-González L.J.
  • Carmona-Sáez P.
  • Sánchez-Ramos J.
  • Álvarez Cubero M.J.
  • Salmerón-Febres L.M.
  • Cabeza Barrera J.
  • Fernández-Quesada F.
... View more Collapse

Pharmacogenomics - 27/07/2016

10.2217/pgs-2016-0056

Cite count: 11 (Scopus)
  • CiteScore: 3.9 (2022)
  • SJR: 0.904 (2016
  • SNIP: 0.76 (2016

Results of genotype-guided antiplatelet therapy in patients who undergone percutaneous coronary intervention with stent.

  • Sánchez-Ramos J.
  • Dávila-Fajardo C.L.
  • Toledo Frías P.
  • Díaz Villamarín X.
  • Martínez-González L.J.
  • Martínez Huertas S.
  • Burillo Gómez F.
  • Caballero Borrego J.
  • Bautista Pavés A.
  • Marín Guzmán M.C.
  • Ramirez Hernández J.A.
  • Correa Vilches C.
  • Cabeza Barrera J.
... View more Collapse

International journal of cardiology - 26/09/2016

10.1016/j.ijcard.2016.09.088

Cite count: 43 (Scopus)
  • CiteScore: 7 (2022)
  • SJR: 1.603 (2016
  • SNIP: 0.896 (2016

The study protocol for a non-randomized controlled clinical trial using a genotype-guided strategy in a dataset of patients who undergone percutaneous coronary intervention with stent.

Data in brief - 20/12/2016

10.1016/j.dib.2016.12.019

  • ORCID

Cost-effectiveness analysis of pharmacogenomics-guided clopidogrel treatment in Spanish patients undergoing percutaneous coronary intervention.

  • Fragoulakis V.
  • Bartsakoulia M.
  • Díaz-Villamarín X.
  • Chalikiopoulou K.
  • Kehagia K.
  • Ramos J.G.S.
  • Martínez-González L.J.
  • Gkotsi M.
  • Katrali E.
  • Skoufas E.
  • Vozikis A.
  • John A.
  • Ali B.R.
  • Wordsworth S.
  • Dávila-Fajardo C.L.
  • Katsila T.
  • Patrinos G.P.
  • Mitropoulou C.
... View more Collapse

The pharmacogenomics journal - 16/01/2019

10.1038/s41397-019-0069-1

Cite count: 19 (Scopus)
  • CiteScore: 6.4 (2022)
  • SJR: 0.981 (2019
  • SNIP: 0.891 (2019
Open Access

Pharmacogenetics in the Treatment of Cardiovascular Diseases and Its Current Progress Regarding Implementation in the Clinical Routine

  • Dávila-Fajardo C.L.
  • Díaz-Villamarín X.
  • Antúnez-Rodríguez A.
  • Fernández-Gómez A.E.
  • García-Navas P.
  • Martínez-González L.J.
  • Dávila-Fajardo J.A.
  • Barrera J.C.
... View more Collapse

Genes - 1/04/2019

10.3390/genes10040261

Cite count: 11 (Scopus)
Open Access

Genetic Variants Affecting Anti-VEGF Drug Response in Polypoidal Choroidal Vasculopathy Patients: A Systematic Review and Meta-Analysis

  • Díaz-Villamarín X.
  • Blánquez-Martínez D.
  • Pozo-Agundo A.
  • Pérez-Gutiérrez A.M.
  • Muñoz-ávila J.I.
  • Antúnez-Rodríguez A.
  • Fernández-Gómez A.E.
  • García-Navas P.
  • Martínez-González L.J.
  • Dávila-Fajardo C.L.
... View more Collapse

Genes - 1/11/2020

10.3390/genes11111335

Cite count: 8 (Scopus)
Open Access

Pharmacogenetic polymorphisms affecting bisoprolol response

  • Castaño-Amores C.
  • Díaz-Villamarín X.
  • Pérez-Gutiérrez A.M.
  • Antúnez-Rodríguez A.
  • Pozo-Agundo A.
  • Moreno-Escobar E.
  • Sánchez-Ramos J.G.
  • Martínez-González L.J.
  • Dávila-Fajardo C.L.
... View more Collapse

Biomedicine & Pharmacotherapy - 1/10/2021

10.1016/j.biopha.2021.112069

Cite count: 6 (Scopus)
  • CiteScore: 12.6 (2022)
  • SJR: 1.194 (2021
  • SNIP: 1.502 (2021
Open Access

Genetic Polymorphisms Affecting Ranibizumab Response in High Myopia Patients

  • Blánquez-Martínez D.
  • Díaz-Villamarín X.
  • Antúnez-Rodríguez A.
  • Pozo-Agundo A.
  • Muñoz-ávila J.I.
  • Martínez-González L.J.
  • Dávila-Fajardo C.L.
... View more Collapse

Pharmaceutics - 1/11/2021

10.3390/pharmaceutics13111973

Cite count: 4 (Scopus)
Open Access

Genetic Polymorphisms in VEGFR Coding Genes (FLT1/KDR) on Ranibizumab Response in High Myopia and Choroidal Neovascularization Patients

  • Blánquez-Martínez D.
  • Díaz-Villamarín X.
  • García-Rodríguez S.
  • Antúnez-Rodríguez A.
  • Pozo-Agundo A.
  • Martínez-González L.J.
  • Muñoz-ávila J.I.
  • Dávila-Fajardo C.L.
... View more Collapse

Pharmaceutics - 26/07/2022

10.3390/pharmaceutics14081555

Cite count: 2 (Scopus)

This author has no books, chapters or theses.

This author has no conferences.

This author has no patents.

This author has no reports or other types of publications.

Scopus: 8

Scopus: 8

Web of Science: 0

  • This author has no currently assigned projects.
Last data update: 6/29/24 4:31 AM
Next scheduled update: 7/6/24 3:00 AM